Lymphoid-specific helicase (HELLS)

Lymphoid-specific helicase (HELLS) is a SNF2-family, SWI/SNF-related ATP-dependent chromatin remodeling protein encoded by the HELLS gene in humans, originally identified for its lymphoid-enriched expression. Although termed a helicase, HELLS functions primarily as a chromatin remodeler whose ATPase activity is stimulated by nucleosomes and that can slide or alter nucleosomes in complex with partner proteins. HELLS is a key epigenetic regulator that contributes to global genome DNA methylation by remodeling chromatin to make DNA accessible to the de novo DNA methyltransferases DNMT3A and DNMT3B, and it also associates with maintenance methyltransferase DNMT1 and histone deacetylases HDAC1 and HDAC2, thereby supporting stable gene silencing during differentiation. It plays crucial roles in normal development and survival in mice, with HELLS knockout causing perinatal lethality, growth retardation, premature aging, and defects in stem/progenitor cell self-renewal, as well as essential functions in male meiosis where loss of HELLS disrupts homologous chromosome synapsis and causes mid-pachytene arrest. At the genome maintenance level, HELLS promotes repair of DNA double-strand breaks by homologous recombination, particularly in heterochromatin during G2, by facilitating DNA end resection and recruitment of CtIP, thereby contributing to genome stability. HELLS is transcriptionally regulated by the RB/E2F pathway, and its overexpression following RB1 loss drives ectopic proliferation and retinoblastoma progression, while genetic ablation of HELLS in retinoblastoma models reduces tumor incidence, delays progression, and improves survival, suggesting that HELLS acts as an oncogenic epigenetic modifier and is a potential therapeutic target. HELLS is mutated or misregulated in several cancers and in some cases of immunodeficiency–centromeric instability–facial anomalies (ICF) syndrome, consistent with its central role in DNA methylation, chromatin packaging, control of Hox genes, stem cell proliferation, and lymphoid tissue development.

Other names

HELLSLSHPASGSMARCA6ICF4Lymphoid-specific helicaseSNF2-like helicaseSWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6

For hypothetical or experimental inhibitors, anticipated mechanisms would include inhibition of HELLS ATPase/helicase activity to block chromatin remodeling; disruption of HELLS interaction with DNA methyltransferases (DNMT3A, DNMT3B, DNMT1) and histone deacetylases (HDAC1, HDAC2) to alter DNA methylation and gene silencing; interference with HELLS-mediated facilitation of homologous recombination repair and cell-cycle gene transcription in tumors